Head Of India’s Biocon Calls For Tax Breaks, Policies To Spur Pharma R&D
This article was originally published in PharmAsia News
Executive Summary
The head of India’s Biocon says the biotechnology industry has great growth potential in the country, but the government needs to shape tax incentives and policies to encourage that growth.